Open access · CC-BY
via OpenAlex
Role of myostatin protein in sarcopenia (aging muscle) after conditioned medium umbilical cord mesenchymal stem cells (secretome) therapy: mini review
Ronald Winardi Kartika, Veronika Maria Sidharta, Tena Djuartina, Ignatio Rika Haryono, Cynthia Retna Sartika, Kris Herawan Timotius
Bali Medical Journal · 2022 · ▲ 5 citations
Stem-cell exhaustion
Altered intercellular communication
Chronic inflammation
Stem-cell therapy
Exercise
Human
Review
Abstract
Umbilical Cord Mesenchyme stem cell (UC-MSCs) /secretome has been applied for treating several diseases, such as cardio-protection and diabetes. Secretome-derived paracrine modulating effects of various growth factors, cytokines, chemokines, angiogenic factors, and exosomes are used in aging therapy. In recent clinical trials on sarcopenia therapy such as pharmaceutical interventions, nutrition, and physical exercise are reported to be effective strategies to reduce sarcopenia. The pathomechanism of the secretome in the treatment of sarcopenia is unclear. This study looked into how secretome might affect myostatin, a biomarker of sarcopenia, at the molecular level. Myostatin, a member of the TGF-family, significantly increases muscle growth when it is absent while suppressing muscle growth when it is present. A bioactive substance called secretome is secreted by MSCs in conditioned conditions. It is rich in growth factors and cytokines, which are crucial for speeding up tissue regeneration. Secretome intervention is a promising approach for treating sarcopenia as showed by its ability to prevent muscle loss and to improve molecular biomarkers.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.15562/bmj.v12i1.3790
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
Kartika, R.W., Sidharta, V.M., Djuartina, T., Haryono, I.R., Sartika, C.R., & Timotius, K.H. (2022). Role of myostatin protein in sarcopenia (aging muscle) after conditioned medium umbilical cord mesenchymal stem cells (secretome) therapy: mini review. <em>Bali Medical Journal</em>. https://doi.org/10.15562/bmj.v12i1.3790
Vancouver
Kartika RW, Sidharta VM, Djuartina T, Haryono IR, Sartika CR, Timotius KH. Role of myostatin protein in sarcopenia (aging muscle) after conditioned medium umbilical cord mesenchymal stem cells (secretome) therapy: mini review. Bali Medical Journal. 2022. doi:10.15562/bmj.v12i1.3790.
BibTeX
@article{ronald2022Roleof,
title = {Role of myostatin protein in sarcopenia (aging muscle) after conditioned medium umbilical cord mesenchymal stem cells (secretome) therapy: mini review},
author = {Ronald Winardi Kartika and Veronika Maria Sidharta and Tena Djuartina and Ignatio Rika Haryono and Cynthia Retna Sartika and Kris Herawan Timotius},
journal = {Bali Medical Journal},
year = {2022},
doi = {10.15562/bmj.v12i1.3790},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinical Cosmetic and Investigational Dermatology 2021
Open access · CC-BY
Mesenchymal Stem Cell Secretome for Dermatology Application: A Review
Elsevier eBooks 2016
Citation only
The Aging Muscle and Sarcopenia
Elsevier eBooks 2019
Citation only
Aging Muscle and Sarcopenia
Zenodo (CERN European Organization for Nuclear Research) 2026
Preprint · OA
Sarcopenia: The Muscle Loss of Aging
Nature Medicine 2018
Preprint · OA
The exerkine apelin reverses age-associated sarcopenia
Sports Health A Multidisciplinary Approach 2013
Preprint · OA